Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 151 Records) |
| Query Trace: Breast Neoplasms and EGFR[original query] |
|---|
| The Investigation of Associations between TP53 rs1042522, BBC3 rs2032809, CCND1 rs9344, EGFR rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis. Diagnostics (Basel, Switzerland) 2021 8 11 (8): . Bekampyt? Justina, Bartnykait? Agn?, Savukaityt? Aist?, Ugenskien? Rasa, Korobeinikova Erika, Gudaitien? Jurgita, Juozaityt? Elo |
| Molecular Characterization, Via Next-Generation Sequencing, of Refractory or Resistant Invasive Breast Carcinoma. Cureus 2021 12 13 (11): e19528. Pose Lapausa Patricia, Soria Comes Teresa, Calabria Inés, Maestu Maiques Inmacula |
| Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing. Cancer science 2021 Oct . Shi Minke, Wang Weiran, Zhang Jinku, Li Bobo, Lv Dongxiao, Wang Danhua, Wang Sizhen, Cheng Dezhi, Ma Tongh |
| [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2021 10 43 (10): 1088-1093. Tang X J, Yang M Y, Zhu L Z, Xu D, Yuan |
| Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World journal of gastroenterology 2021 10 27 (36): 6093-6109. Rah Bilal, Banday Manzoor Ahmad, Bhat Gh Rasool, Shah Omar J, Jeelani Humira, Kawoosa Fizalah, Yousuf Tahira, Afroze D |
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population. BMC medical genomics 2022 07 15 (1): 146. Huang Qingfeng, Zhou Yang, Wang Bowen, Zhao Yi, Zhang Fengxia, Ding Bow |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association = Taiwan yi zhi 2022 6 121 (12): 2538-2547. Lin Po-Han, Tseng Ling-Ming, Lee Yi-Hsuan, Chen Shou-Tung, Yeh Dah-Cherng, Dai Ming-Shen, Liu Liang-Chih, Wang Ming-Yang, Lo Chiao, Chang Stanley, Tan Kien Thiam, Chen Shu-Jen, Kuo Sung-Hsin, Huang Chiun-She |
| PROshot: Locoregional Therapy for Metastatic Breast Cancer, Abiraterone in Very High-Risk Prostate Cancer, Neoadjuvant Chemoradiation for Resectable Pancreatic Cancer, Radiation for Oligometastatic EGFR-mutated Lung Cancer, and PORT for N2 Lung Cancer. Practical radiation oncology 2022 5 12 (3): 179-184. Dulaney Caleb, Dover Lau |
| KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer. Journal of cancer research and clinical oncology 2022 4 . Shimozaki Keitaro, Shinozaki Eiji, Yamamoto Noriko, Imamura Yu, Osumi Hiroki, Nakayama Izuma, Wakatsuki Takeru, Ooki Akira, Takahari Daisuke, Ogura Mariko, Chin Keisho, Watanabe Masayuki, Yamaguchi Kens |
| Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors. Translational cancer research 2021 Dec 10 (12): 5204-5211. Jang Yoon Jung, Kim Seo Yun, Jung Hong Kyu, Kim Hye-Ryoun, Kim Cheol Hyeon, Lee Hyo-Rak, Kang Hye Jin, Yang Sung Hyun, Seol Hyesil, Na Im |
| Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types. JCO precision oncology 2022 Feb 6 e2100325. Yin Yan, Song Lijie, Shi Dongsheng, Liu Bin, Li Xiangke, Yang Minjie, Liu Bihao, Wang Dejuan, Qin Jianw |
| The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
| Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer medicine 2022 11 . Lai Xiaojing, Yu Ruoying, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Li Yang, Zhang Ying, Ding Qingqi |
| High rate of epidermal growth factor receptor-mutated primary lung cancer in patients with primary breast cancer. Frontiers in oncology 2022 10 12 985734. Zeng Tianyu, Xu Hai, Liu Yincheng, Sun Chunxiao, Yang Fan, Liang Yan, Huang Xiang, Fu Ziyi, Li Wei, Yin Yongm |
| Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study. Clinical lung cancer 2023 6 . Kevin Yu Wang, Chung-Shien Lee, Prashant Vempati, Rajiv Sharma, Nina Kohn, Nagashree Seethara |
| Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series. Pharmacy (Basel, Switzerland) 2023 2 11 (1): . Šimi?evi? Livija, Sliškovi? Ana Marija, Kirhmajer Majda Vrki?, Ganoci Lana, Holik Hrvoje, Pali? Jozefina, Samardži? Jure, Božina Tama |
| HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment. Cancers 2023 2 15 (3): . Novillo Apolonia, Gaibar María, Romero-Lorca Alicia, Malón Diego, Antón Beatriz, Moreno Amalia, Fernández-Santander A |
| Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer. BMC medicine 2023 12 21 (1): 493. Zhaoyun Liu, Bo Yu, Mu Su, Chenxi Yuan, Cuicui Liu, Xinzhao Wang, Xiang Song, Chao Li, Fukai Wang, Jianli Ma, Meng Wu, Dawei Chen, Jinming Yu, Zhiyong |
| Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
| The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions. Frontiers in pharmacology 2024 9 15 1420174. Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, Margherita Nuti, Marco Orleni, Sara Gagno, Elena De Mattia, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Ronca |
| Ivonescimab: First Approval. Drugs 2024 7 . Sohita Dhill |
| Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients. Life (Basel, Switzerland) 2024 6 14 (6): . Nataša Medi?-Miliji?, Irena Jovani?, Milica Nedeljkovi?, Ivan Markovi?, Igor Spurni?, Zorka Milovanovi?, Nejla Ademovi?, Tijana Tomi?, Nasta Tani?, Nikola Tan |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. Cancer medicine 2024 6 13 (12): e7384. Shang-Hung Chen, Ka-Po Tse, Yen-Jung Lu, Shu-Jen Chen, Yu-Feng Tian, Kien Thiam Tan, Chien-Feng |
| Incidental detection of ground glass nodules and primary lung cancer in patients with breast cancer: prevalence and long-term follow-up on chest computed tomography. Journal of thoracic disease 2024 4 16 (3): 1804-1814. Hye Sun Ryu, Han Na Lee, Jung Im Kim, Jung Kyu Ryu, Yu Jin L |
| Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer. Cancer biomarkers : section A of Disease markers 2024 1 . Ahmed Saeed Abd ELhafeez, Hala Mostafa Ghanem, Menha Swellam, AlShaimaa Mohamed Ta |
| Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
- Page last reviewed:Feb 1, 2024
- Content source: